Alaunos Therapeutics, Inc. (TCRT) Operating income 2016–2025
Alaunos Therapeutics, Inc. (TCRT) annual operating income history from SEC filings — each fiscal year as reported.
-$4.2MFY2025 · since FY2016: -$165.3M → -$4.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.2M | +12.2% |
| FY2024 | -$4.8M | +86.0% |
| FY2023 | -$34.3M | +2.4% |
| FY2022 | -$35.1M | +54.7% |
| FY2021 | -$77.5M | +3.5% |
| FY2020 | -$80.4M | -38.9% |
| FY2019 | -$57.9M | -7.3% |
| FY2018 | -$53.9M | -0.8% |
| FY2017 | -$53.5M | +67.6% |
| FY2016 | -$165.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice